Global Organ On Chip Market

Organ On Chip Comprehensive Study by Type (Liver, Heart, Lung, Other), Application (Drug Discovery, Toxicology Research, Other), End User (Pharmaceutical and Biotechnology Companies, Academic and Research Institutes, Other) Players and Region - Global Market Outlook to 2026

Organ On Chip Market by XX Submarkets | Forecast Years 2022-2027  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
What is Organ On Chip?
The Organ on chip is manufactured to precisely recreate the mechanical forces and natural physiology that cells experience in the human body. Organ on chip are lined with living human cells and their tiny fluidic channels reproduce blood and air flow just as in the human body. Organ on chip provides a novel in vitro platform with a possibility of reproducing physiological functions of in vivo tissue, more accurately than conventional cell-based model systems, this has led to significant growth in the forecast period.

The market study is broken down by Type (Liver, Heart, Lung and Other), by Application (Drug Discovery, Toxicology Research and Other) and major geographies with country level break-up. and may see market size of USD5.94 Billion by 2026.

The global organ-on-chip market is highly competitive and consists of several major players. In terms of market share, few of the major players currently dominate the market. The presence of significant market players, increasing the overall competitive rivalry in the market. Product advancements and improvements in the organ-on-chip platforms by the major players are increasing the competitive rivalry. Analysts at AMA Research estimates that Players from United States will contribute to the maximum growth of Global Organ On Chip market throughout the predicted period. Established and emerging Players should take a closer view at their existing organizations and reinvent traditional business and operating models to adapt to the future.

AxoSim Inc. (United States), BiomimX SRL (Italy), Emulate Inc. (United States), Elveflow (France), Hurel Corporation (United States), Nortis, Inc. (United States), TARA Biosystems, Inc. (United States), TissUse GmbH (Germany), InSphero AG (Switzerland) and MIMETAS BV (United States) are some of the key players that are part of study coverage.

Segmentation Overview
AdvanceMarketAnalytics has segmented the market of Global Organ On Chip market by Type, Application and Region.

On the basis of geography, the market of Organ On Chip has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by End User, the sub-segment i.e. Pharmaceutical and Biotechnology Companies will boost the Organ On Chip market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.

On 13th November 2018, During the third International Organ-on-Chip Symposium, held in November 2018, the European Organ-on-Chip Society (EUROoCS) was officially launched. The purpose of the Society is to encourage and develop Organ-on-Chip research, and to provide and opportunities to share and advance the knowledge and expertise in this field towards better health for everyone.


Market Trend
  • Rising Scientific Knowledge and Modern High-Tech Advancements
  • in Micro- and Nano-scales Fabrication Technologies

Market Drivers
  • Growing Requirement of Alternative for Animal Testing Globally
  • Increasing Demand for Early Detection of Drug Toxicity

Opportunities
  • Rising New Products Launches and Advancements in Technology and Research

Restraints
  • Rising Complexity of Organ-on-chip Models


Key Target Audience
Organ On-Chip Manufacturers, Pharmaceuticals Industries, Healthcare Research Institutes, Potential Technology Investors, Regulatory & Government Bodies, Downstream Vendors, End Users and Other

About Approach
To evaluate and validate the market size various sources including primary and secondary analysis is utilized. AMA Research follows regulatory standards such as NAICS/SIC/ICB/TRCB, to have the better understanding of the market. The market study is conducted on basis of more than 200 companies dealing in the market regional as well as global areas with purpose to understand company’s positioning regarding market value, volume and their market share for regional as well as global.

Further to bring relevance specific to any niche market we set and apply number of criteria like Geographic Footprints, Regional Segments of Revenue, Operational Centres, etc. The next step is to finalize a team (In-House + Data Agencies) who then starts collecting C & D level executives and profiles, Industry experts, Opinion leaders etc. and work towards appointment generation.

The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, analyst team keeps preparing set of questionnaires and after getting appointee list; the target audience are then tapped and segregated with various mediums and channels that are feasible for making connection that includes email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey etc.

Report Objectives / Segmentation Covered

By Type
  • Liver
  • Heart
  • Lung
  • Other
By Application
  • Drug Discovery
  • Toxicology Research
  • Other
By End User
  • Pharmaceutical and Biotechnology Companies
  • Academic and Research Institutes
  • Other

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Growing Requirement of Alternative for Animal Testing Globally
      • 3.2.2. Increasing Demand for Early Detection of Drug Toxicity
    • 3.3. Market Trends
      • 3.3.1. Rising Scientific Knowledge and Modern High-Tech Advancements
      • 3.3.2. In Micro- and Nano-scales Fabrication Technologies
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Organ On Chip, by Type, Application, End User and Region (value) (2015-2020)
    • 5.1. Introduction
    • 5.2. Global Organ On Chip (Value)
      • 5.2.1. Global Organ On Chip by: Type (Value)
        • 5.2.1.1. Liver
        • 5.2.1.2. Heart
        • 5.2.1.3. Lung
        • 5.2.1.4. Other
      • 5.2.2. Global Organ On Chip by: Application (Value)
        • 5.2.2.1. Drug Discovery
        • 5.2.2.2. Toxicology Research
        • 5.2.2.3. Other
      • 5.2.3. Global Organ On Chip by: End User (Value)
        • 5.2.3.1. Pharmaceutical and Biotechnology Companies
        • 5.2.3.2. Academic and Research Institutes
        • 5.2.3.3. Other
      • 5.2.4. Global Organ On Chip Region
        • 5.2.4.1. South America
          • 5.2.4.1.1. Brazil
          • 5.2.4.1.2. Argentina
          • 5.2.4.1.3. Rest of South America
        • 5.2.4.2. Asia Pacific
          • 5.2.4.2.1. China
          • 5.2.4.2.2. Japan
          • 5.2.4.2.3. India
          • 5.2.4.2.4. South Korea
          • 5.2.4.2.5. Taiwan
          • 5.2.4.2.6. Australia
          • 5.2.4.2.7. Rest of Asia-Pacific
        • 5.2.4.3. Europe
          • 5.2.4.3.1. Germany
          • 5.2.4.3.2. France
          • 5.2.4.3.3. Italy
          • 5.2.4.3.4. United Kingdom
          • 5.2.4.3.5. Netherlands
          • 5.2.4.3.6. Rest of Europe
        • 5.2.4.4. MEA
          • 5.2.4.4.1. Middle East
          • 5.2.4.4.2. Africa
        • 5.2.4.5. North America
          • 5.2.4.5.1. United States
          • 5.2.4.5.2. Canada
          • 5.2.4.5.3. Mexico
  • 6. Organ On Chip: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2020)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. AxoSim Inc. (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. BiomimX SRL (Italy)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Emulate Inc. (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Elveflow (France)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Hurel Corporation (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Nortis, Inc. (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. TARA Biosystems, Inc. (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. TissUse GmbH (Germany)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. InSphero AG (Switzerland)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. MIMETAS BV (United States)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Organ On Chip Sale, by Type, Application, End User and Region (value) (2021-2026)
    • 7.1. Introduction
    • 7.2. Global Organ On Chip (Value)
      • 7.2.1. Global Organ On Chip by: Type (Value)
        • 7.2.1.1. Liver
        • 7.2.1.2. Heart
        • 7.2.1.3. Lung
        • 7.2.1.4. Other
      • 7.2.2. Global Organ On Chip by: Application (Value)
        • 7.2.2.1. Drug Discovery
        • 7.2.2.2. Toxicology Research
        • 7.2.2.3. Other
      • 7.2.3. Global Organ On Chip by: End User (Value)
        • 7.2.3.1. Pharmaceutical and Biotechnology Companies
        • 7.2.3.2. Academic and Research Institutes
        • 7.2.3.3. Other
      • 7.2.4. Global Organ On Chip Region
        • 7.2.4.1. South America
          • 7.2.4.1.1. Brazil
          • 7.2.4.1.2. Argentina
          • 7.2.4.1.3. Rest of South America
        • 7.2.4.2. Asia Pacific
          • 7.2.4.2.1. China
          • 7.2.4.2.2. Japan
          • 7.2.4.2.3. India
          • 7.2.4.2.4. South Korea
          • 7.2.4.2.5. Taiwan
          • 7.2.4.2.6. Australia
          • 7.2.4.2.7. Rest of Asia-Pacific
        • 7.2.4.3. Europe
          • 7.2.4.3.1. Germany
          • 7.2.4.3.2. France
          • 7.2.4.3.3. Italy
          • 7.2.4.3.4. United Kingdom
          • 7.2.4.3.5. Netherlands
          • 7.2.4.3.6. Rest of Europe
        • 7.2.4.4. MEA
          • 7.2.4.4.1. Middle East
          • 7.2.4.4.2. Africa
        • 7.2.4.5. North America
          • 7.2.4.5.1. United States
          • 7.2.4.5.2. Canada
          • 7.2.4.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Organ On Chip: by Type(USD Billion)
  • Table 2. Organ On Chip Liver , by Region USD Billion (2015-2020)
  • Table 3. Organ On Chip Heart , by Region USD Billion (2015-2020)
  • Table 4. Organ On Chip Lung , by Region USD Billion (2015-2020)
  • Table 5. Organ On Chip Other , by Region USD Billion (2015-2020)
  • Table 6. Organ On Chip: by Application(USD Billion)
  • Table 7. Organ On Chip Drug Discovery , by Region USD Billion (2015-2020)
  • Table 8. Organ On Chip Toxicology Research , by Region USD Billion (2015-2020)
  • Table 9. Organ On Chip Other , by Region USD Billion (2015-2020)
  • Table 10. Organ On Chip: by End User(USD Billion)
  • Table 11. Organ On Chip Pharmaceutical and Biotechnology Companies , by Region USD Billion (2015-2020)
  • Table 12. Organ On Chip Academic and Research Institutes , by Region USD Billion (2015-2020)
  • Table 13. Organ On Chip Other , by Region USD Billion (2015-2020)
  • Table 14. South America Organ On Chip, by Country USD Billion (2015-2020)
  • Table 15. South America Organ On Chip, by Type USD Billion (2015-2020)
  • Table 16. South America Organ On Chip, by Application USD Billion (2015-2020)
  • Table 17. South America Organ On Chip, by End User USD Billion (2015-2020)
  • Table 18. Brazil Organ On Chip, by Type USD Billion (2015-2020)
  • Table 19. Brazil Organ On Chip, by Application USD Billion (2015-2020)
  • Table 20. Brazil Organ On Chip, by End User USD Billion (2015-2020)
  • Table 21. Argentina Organ On Chip, by Type USD Billion (2015-2020)
  • Table 22. Argentina Organ On Chip, by Application USD Billion (2015-2020)
  • Table 23. Argentina Organ On Chip, by End User USD Billion (2015-2020)
  • Table 24. Rest of South America Organ On Chip, by Type USD Billion (2015-2020)
  • Table 25. Rest of South America Organ On Chip, by Application USD Billion (2015-2020)
  • Table 26. Rest of South America Organ On Chip, by End User USD Billion (2015-2020)
  • Table 27. Asia Pacific Organ On Chip, by Country USD Billion (2015-2020)
  • Table 28. Asia Pacific Organ On Chip, by Type USD Billion (2015-2020)
  • Table 29. Asia Pacific Organ On Chip, by Application USD Billion (2015-2020)
  • Table 30. Asia Pacific Organ On Chip, by End User USD Billion (2015-2020)
  • Table 31. China Organ On Chip, by Type USD Billion (2015-2020)
  • Table 32. China Organ On Chip, by Application USD Billion (2015-2020)
  • Table 33. China Organ On Chip, by End User USD Billion (2015-2020)
  • Table 34. Japan Organ On Chip, by Type USD Billion (2015-2020)
  • Table 35. Japan Organ On Chip, by Application USD Billion (2015-2020)
  • Table 36. Japan Organ On Chip, by End User USD Billion (2015-2020)
  • Table 37. India Organ On Chip, by Type USD Billion (2015-2020)
  • Table 38. India Organ On Chip, by Application USD Billion (2015-2020)
  • Table 39. India Organ On Chip, by End User USD Billion (2015-2020)
  • Table 40. South Korea Organ On Chip, by Type USD Billion (2015-2020)
  • Table 41. South Korea Organ On Chip, by Application USD Billion (2015-2020)
  • Table 42. South Korea Organ On Chip, by End User USD Billion (2015-2020)
  • Table 43. Taiwan Organ On Chip, by Type USD Billion (2015-2020)
  • Table 44. Taiwan Organ On Chip, by Application USD Billion (2015-2020)
  • Table 45. Taiwan Organ On Chip, by End User USD Billion (2015-2020)
  • Table 46. Australia Organ On Chip, by Type USD Billion (2015-2020)
  • Table 47. Australia Organ On Chip, by Application USD Billion (2015-2020)
  • Table 48. Australia Organ On Chip, by End User USD Billion (2015-2020)
  • Table 49. Rest of Asia-Pacific Organ On Chip, by Type USD Billion (2015-2020)
  • Table 50. Rest of Asia-Pacific Organ On Chip, by Application USD Billion (2015-2020)
  • Table 51. Rest of Asia-Pacific Organ On Chip, by End User USD Billion (2015-2020)
  • Table 52. Europe Organ On Chip, by Country USD Billion (2015-2020)
  • Table 53. Europe Organ On Chip, by Type USD Billion (2015-2020)
  • Table 54. Europe Organ On Chip, by Application USD Billion (2015-2020)
  • Table 55. Europe Organ On Chip, by End User USD Billion (2015-2020)
  • Table 56. Germany Organ On Chip, by Type USD Billion (2015-2020)
  • Table 57. Germany Organ On Chip, by Application USD Billion (2015-2020)
  • Table 58. Germany Organ On Chip, by End User USD Billion (2015-2020)
  • Table 59. France Organ On Chip, by Type USD Billion (2015-2020)
  • Table 60. France Organ On Chip, by Application USD Billion (2015-2020)
  • Table 61. France Organ On Chip, by End User USD Billion (2015-2020)
  • Table 62. Italy Organ On Chip, by Type USD Billion (2015-2020)
  • Table 63. Italy Organ On Chip, by Application USD Billion (2015-2020)
  • Table 64. Italy Organ On Chip, by End User USD Billion (2015-2020)
  • Table 65. United Kingdom Organ On Chip, by Type USD Billion (2015-2020)
  • Table 66. United Kingdom Organ On Chip, by Application USD Billion (2015-2020)
  • Table 67. United Kingdom Organ On Chip, by End User USD Billion (2015-2020)
  • Table 68. Netherlands Organ On Chip, by Type USD Billion (2015-2020)
  • Table 69. Netherlands Organ On Chip, by Application USD Billion (2015-2020)
  • Table 70. Netherlands Organ On Chip, by End User USD Billion (2015-2020)
  • Table 71. Rest of Europe Organ On Chip, by Type USD Billion (2015-2020)
  • Table 72. Rest of Europe Organ On Chip, by Application USD Billion (2015-2020)
  • Table 73. Rest of Europe Organ On Chip, by End User USD Billion (2015-2020)
  • Table 74. MEA Organ On Chip, by Country USD Billion (2015-2020)
  • Table 75. MEA Organ On Chip, by Type USD Billion (2015-2020)
  • Table 76. MEA Organ On Chip, by Application USD Billion (2015-2020)
  • Table 77. MEA Organ On Chip, by End User USD Billion (2015-2020)
  • Table 78. Middle East Organ On Chip, by Type USD Billion (2015-2020)
  • Table 79. Middle East Organ On Chip, by Application USD Billion (2015-2020)
  • Table 80. Middle East Organ On Chip, by End User USD Billion (2015-2020)
  • Table 81. Africa Organ On Chip, by Type USD Billion (2015-2020)
  • Table 82. Africa Organ On Chip, by Application USD Billion (2015-2020)
  • Table 83. Africa Organ On Chip, by End User USD Billion (2015-2020)
  • Table 84. North America Organ On Chip, by Country USD Billion (2015-2020)
  • Table 85. North America Organ On Chip, by Type USD Billion (2015-2020)
  • Table 86. North America Organ On Chip, by Application USD Billion (2015-2020)
  • Table 87. North America Organ On Chip, by End User USD Billion (2015-2020)
  • Table 88. United States Organ On Chip, by Type USD Billion (2015-2020)
  • Table 89. United States Organ On Chip, by Application USD Billion (2015-2020)
  • Table 90. United States Organ On Chip, by End User USD Billion (2015-2020)
  • Table 91. Canada Organ On Chip, by Type USD Billion (2015-2020)
  • Table 92. Canada Organ On Chip, by Application USD Billion (2015-2020)
  • Table 93. Canada Organ On Chip, by End User USD Billion (2015-2020)
  • Table 94. Mexico Organ On Chip, by Type USD Billion (2015-2020)
  • Table 95. Mexico Organ On Chip, by Application USD Billion (2015-2020)
  • Table 96. Mexico Organ On Chip, by End User USD Billion (2015-2020)
  • Table 97. Company Basic Information, Sales Area and Its Competitors
  • Table 98. Company Basic Information, Sales Area and Its Competitors
  • Table 99. Company Basic Information, Sales Area and Its Competitors
  • Table 100. Company Basic Information, Sales Area and Its Competitors
  • Table 101. Company Basic Information, Sales Area and Its Competitors
  • Table 102. Company Basic Information, Sales Area and Its Competitors
  • Table 103. Company Basic Information, Sales Area and Its Competitors
  • Table 104. Company Basic Information, Sales Area and Its Competitors
  • Table 105. Company Basic Information, Sales Area and Its Competitors
  • Table 106. Company Basic Information, Sales Area and Its Competitors
  • Table 107. Organ On Chip: by Type(USD Billion)
  • Table 108. Organ On Chip Liver , by Region USD Billion (2021-2026)
  • Table 109. Organ On Chip Heart , by Region USD Billion (2021-2026)
  • Table 110. Organ On Chip Lung , by Region USD Billion (2021-2026)
  • Table 111. Organ On Chip Other , by Region USD Billion (2021-2026)
  • Table 112. Organ On Chip: by Application(USD Billion)
  • Table 113. Organ On Chip Drug Discovery , by Region USD Billion (2021-2026)
  • Table 114. Organ On Chip Toxicology Research , by Region USD Billion (2021-2026)
  • Table 115. Organ On Chip Other , by Region USD Billion (2021-2026)
  • Table 116. Organ On Chip: by End User(USD Billion)
  • Table 117. Organ On Chip Pharmaceutical and Biotechnology Companies , by Region USD Billion (2021-2026)
  • Table 118. Organ On Chip Academic and Research Institutes , by Region USD Billion (2021-2026)
  • Table 119. Organ On Chip Other , by Region USD Billion (2021-2026)
  • Table 120. South America Organ On Chip, by Country USD Billion (2021-2026)
  • Table 121. South America Organ On Chip, by Type USD Billion (2021-2026)
  • Table 122. South America Organ On Chip, by Application USD Billion (2021-2026)
  • Table 123. South America Organ On Chip, by End User USD Billion (2021-2026)
  • Table 124. Brazil Organ On Chip, by Type USD Billion (2021-2026)
  • Table 125. Brazil Organ On Chip, by Application USD Billion (2021-2026)
  • Table 126. Brazil Organ On Chip, by End User USD Billion (2021-2026)
  • Table 127. Argentina Organ On Chip, by Type USD Billion (2021-2026)
  • Table 128. Argentina Organ On Chip, by Application USD Billion (2021-2026)
  • Table 129. Argentina Organ On Chip, by End User USD Billion (2021-2026)
  • Table 130. Rest of South America Organ On Chip, by Type USD Billion (2021-2026)
  • Table 131. Rest of South America Organ On Chip, by Application USD Billion (2021-2026)
  • Table 132. Rest of South America Organ On Chip, by End User USD Billion (2021-2026)
  • Table 133. Asia Pacific Organ On Chip, by Country USD Billion (2021-2026)
  • Table 134. Asia Pacific Organ On Chip, by Type USD Billion (2021-2026)
  • Table 135. Asia Pacific Organ On Chip, by Application USD Billion (2021-2026)
  • Table 136. Asia Pacific Organ On Chip, by End User USD Billion (2021-2026)
  • Table 137. China Organ On Chip, by Type USD Billion (2021-2026)
  • Table 138. China Organ On Chip, by Application USD Billion (2021-2026)
  • Table 139. China Organ On Chip, by End User USD Billion (2021-2026)
  • Table 140. Japan Organ On Chip, by Type USD Billion (2021-2026)
  • Table 141. Japan Organ On Chip, by Application USD Billion (2021-2026)
  • Table 142. Japan Organ On Chip, by End User USD Billion (2021-2026)
  • Table 143. India Organ On Chip, by Type USD Billion (2021-2026)
  • Table 144. India Organ On Chip, by Application USD Billion (2021-2026)
  • Table 145. India Organ On Chip, by End User USD Billion (2021-2026)
  • Table 146. South Korea Organ On Chip, by Type USD Billion (2021-2026)
  • Table 147. South Korea Organ On Chip, by Application USD Billion (2021-2026)
  • Table 148. South Korea Organ On Chip, by End User USD Billion (2021-2026)
  • Table 149. Taiwan Organ On Chip, by Type USD Billion (2021-2026)
  • Table 150. Taiwan Organ On Chip, by Application USD Billion (2021-2026)
  • Table 151. Taiwan Organ On Chip, by End User USD Billion (2021-2026)
  • Table 152. Australia Organ On Chip, by Type USD Billion (2021-2026)
  • Table 153. Australia Organ On Chip, by Application USD Billion (2021-2026)
  • Table 154. Australia Organ On Chip, by End User USD Billion (2021-2026)
  • Table 155. Rest of Asia-Pacific Organ On Chip, by Type USD Billion (2021-2026)
  • Table 156. Rest of Asia-Pacific Organ On Chip, by Application USD Billion (2021-2026)
  • Table 157. Rest of Asia-Pacific Organ On Chip, by End User USD Billion (2021-2026)
  • Table 158. Europe Organ On Chip, by Country USD Billion (2021-2026)
  • Table 159. Europe Organ On Chip, by Type USD Billion (2021-2026)
  • Table 160. Europe Organ On Chip, by Application USD Billion (2021-2026)
  • Table 161. Europe Organ On Chip, by End User USD Billion (2021-2026)
  • Table 162. Germany Organ On Chip, by Type USD Billion (2021-2026)
  • Table 163. Germany Organ On Chip, by Application USD Billion (2021-2026)
  • Table 164. Germany Organ On Chip, by End User USD Billion (2021-2026)
  • Table 165. France Organ On Chip, by Type USD Billion (2021-2026)
  • Table 166. France Organ On Chip, by Application USD Billion (2021-2026)
  • Table 167. France Organ On Chip, by End User USD Billion (2021-2026)
  • Table 168. Italy Organ On Chip, by Type USD Billion (2021-2026)
  • Table 169. Italy Organ On Chip, by Application USD Billion (2021-2026)
  • Table 170. Italy Organ On Chip, by End User USD Billion (2021-2026)
  • Table 171. United Kingdom Organ On Chip, by Type USD Billion (2021-2026)
  • Table 172. United Kingdom Organ On Chip, by Application USD Billion (2021-2026)
  • Table 173. United Kingdom Organ On Chip, by End User USD Billion (2021-2026)
  • Table 174. Netherlands Organ On Chip, by Type USD Billion (2021-2026)
  • Table 175. Netherlands Organ On Chip, by Application USD Billion (2021-2026)
  • Table 176. Netherlands Organ On Chip, by End User USD Billion (2021-2026)
  • Table 177. Rest of Europe Organ On Chip, by Type USD Billion (2021-2026)
  • Table 178. Rest of Europe Organ On Chip, by Application USD Billion (2021-2026)
  • Table 179. Rest of Europe Organ On Chip, by End User USD Billion (2021-2026)
  • Table 180. MEA Organ On Chip, by Country USD Billion (2021-2026)
  • Table 181. MEA Organ On Chip, by Type USD Billion (2021-2026)
  • Table 182. MEA Organ On Chip, by Application USD Billion (2021-2026)
  • Table 183. MEA Organ On Chip, by End User USD Billion (2021-2026)
  • Table 184. Middle East Organ On Chip, by Type USD Billion (2021-2026)
  • Table 185. Middle East Organ On Chip, by Application USD Billion (2021-2026)
  • Table 186. Middle East Organ On Chip, by End User USD Billion (2021-2026)
  • Table 187. Africa Organ On Chip, by Type USD Billion (2021-2026)
  • Table 188. Africa Organ On Chip, by Application USD Billion (2021-2026)
  • Table 189. Africa Organ On Chip, by End User USD Billion (2021-2026)
  • Table 190. North America Organ On Chip, by Country USD Billion (2021-2026)
  • Table 191. North America Organ On Chip, by Type USD Billion (2021-2026)
  • Table 192. North America Organ On Chip, by Application USD Billion (2021-2026)
  • Table 193. North America Organ On Chip, by End User USD Billion (2021-2026)
  • Table 194. United States Organ On Chip, by Type USD Billion (2021-2026)
  • Table 195. United States Organ On Chip, by Application USD Billion (2021-2026)
  • Table 196. United States Organ On Chip, by End User USD Billion (2021-2026)
  • Table 197. Canada Organ On Chip, by Type USD Billion (2021-2026)
  • Table 198. Canada Organ On Chip, by Application USD Billion (2021-2026)
  • Table 199. Canada Organ On Chip, by End User USD Billion (2021-2026)
  • Table 200. Mexico Organ On Chip, by Type USD Billion (2021-2026)
  • Table 201. Mexico Organ On Chip, by Application USD Billion (2021-2026)
  • Table 202. Mexico Organ On Chip, by End User USD Billion (2021-2026)
  • Table 203. Research Programs/Design for This Report
  • Table 204. Key Data Information from Secondary Sources
  • Table 205. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Organ On Chip: by Type USD Billion (2015-2020)
  • Figure 5. Global Organ On Chip: by Application USD Billion (2015-2020)
  • Figure 6. Global Organ On Chip: by End User USD Billion (2015-2020)
  • Figure 7. South America Organ On Chip Share (%), by Country
  • Figure 8. Asia Pacific Organ On Chip Share (%), by Country
  • Figure 9. Europe Organ On Chip Share (%), by Country
  • Figure 10. MEA Organ On Chip Share (%), by Country
  • Figure 11. North America Organ On Chip Share (%), by Country
  • Figure 12. Global Organ On Chip share by Players 2020 (%)
  • Figure 13. Global Organ On Chip share by Players (Top 3) 2020(%)
  • Figure 14. Global Organ On Chip share by Players (Top 5) 2020(%)
  • Figure 15. BCG Matrix for key Companies
  • Figure 16. AxoSim Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 17. AxoSim Inc. (United States) Revenue: by Geography 2020
  • Figure 18. BiomimX SRL (Italy) Revenue, Net Income and Gross profit
  • Figure 19. BiomimX SRL (Italy) Revenue: by Geography 2020
  • Figure 20. Emulate Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 21. Emulate Inc. (United States) Revenue: by Geography 2020
  • Figure 22. Elveflow (France) Revenue, Net Income and Gross profit
  • Figure 23. Elveflow (France) Revenue: by Geography 2020
  • Figure 24. Hurel Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 25. Hurel Corporation (United States) Revenue: by Geography 2020
  • Figure 26. Nortis, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 27. Nortis, Inc. (United States) Revenue: by Geography 2020
  • Figure 28. TARA Biosystems, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 29. TARA Biosystems, Inc. (United States) Revenue: by Geography 2020
  • Figure 30. TissUse GmbH (Germany) Revenue, Net Income and Gross profit
  • Figure 31. TissUse GmbH (Germany) Revenue: by Geography 2020
  • Figure 32. InSphero AG (Switzerland) Revenue, Net Income and Gross profit
  • Figure 33. InSphero AG (Switzerland) Revenue: by Geography 2020
  • Figure 34. MIMETAS BV (United States) Revenue, Net Income and Gross profit
  • Figure 35. MIMETAS BV (United States) Revenue: by Geography 2020
  • Figure 36. Global Organ On Chip: by Type USD Billion (2021-2026)
  • Figure 37. Global Organ On Chip: by Application USD Billion (2021-2026)
  • Figure 38. Global Organ On Chip: by End User USD Billion (2021-2026)
  • Figure 39. South America Organ On Chip Share (%), by Country
  • Figure 40. Asia Pacific Organ On Chip Share (%), by Country
  • Figure 41. Europe Organ On Chip Share (%), by Country
  • Figure 42. MEA Organ On Chip Share (%), by Country
  • Figure 43. North America Organ On Chip Share (%), by Country
List of companies from research coverage that are profiled in the study
  • AxoSim Inc. (United States)
  • BiomimX SRL (Italy)
  • Emulate Inc. (United States)
  • Elveflow (France)
  • Hurel Corporation (United States)
  • Nortis, Inc. (United States)
  • TARA Biosystems, Inc. (United States)
  • TissUse GmbH (Germany)
  • InSphero AG (Switzerland)
  • MIMETAS BV (United States)
Select User Access Type

Key Highlights of Report


Sep 2021 213 Pages 57 Tables Base Year: 2021 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Organ On Chip Market Quantitative research analysis
Global Organ On Chip Market Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The standard version of the report profiles players such as AxoSim Inc. (United States), BiomimX SRL (Italy), Emulate Inc. (United States), Elveflow (France), Hurel Corporation (United States), Nortis, Inc. (United States), TARA Biosystems, Inc. (United States), TissUse GmbH (Germany), InSphero AG (Switzerland) and MIMETAS BV (United States) etc.
The Study can be customized subject to feasibility and data availability. Please connect with our sales representative for further information.
Analysts at AMA estimates Organ On Chip Market to reach USD5.94 Billion by 2026.

Know More About Global Organ On Chip Market Report?

Have a Query? Click Here

Other Related Reports

Graphic Cards Comprehensive Study by Type (HD Graphics Cards, Integrated Graphics Cards, Discrete Graphics Cards), Application (Computer-Aided Design, Flight Simulation), End Use Verticals (Electroni...
$ 3750
Ultrasonic Proximity Switch Comprehensive Study by Type (Single Switching Output DC, Double Switching Output DC, Analog Output, Analog Output Plus Switched Output), Application (Distance Management, ...
$ 3650
Speed Sensors- Comprehensive Study by Type (Active Speed Sensors, Passive Speed Sensors), Application (Industries, Electronics, Aerospace and Defence, Other), Material (Brass, Steel, Copper, Poly Vin...
$ 3350
IC Systems Comprehensive Study by Application (Computer Systems, Communication Systems, Consumer Systems, Automotive Systems, Industrial Systems, Others), Components (Transistors, Diodes, Resistors, ...
$ 3750
Portable Flood Light Comprehensive Study by Type (Halogen, LED, Fluorescent, Others), Application (House, Auditorium, Basements, Warehouse, Halls, Street lights, Others), Mounting (Wheel mounting, Po...
$ 3750
System in Package Technology Comprehensive Study by Application (Consumer Electronics, Medical, Automotive, Telecom, Aerospace and Defense, Industrial System, Others), Package Type (Ball Grid Array (...
$ 3750